What is the Purpose of this Study?
This study focuses on patients with severe traumatic brain injury (TBI). The purpose of the study is to compare two ways of treating patients with brain injury. Participants will be randomly assigned to one of two groups. One group will receive medical care based on monitoring of pressure in the brain (intracranial pressure or ICP) alone. The other group will receive medical care based on ICP and the amount of oxygen in the brain. In both strategies, doctors will monitor and modify the medical care provided in order to try to improve some measure of the brain's health. It is not yet known which measure of the brain's health, intracranial pressure or oxygen level, is more important. The study results will help determine whether using both methods is better than using one method alone for the treatment of TBI. Both methods are used in standard care, and monitoring devices are approved by the U.S. Food and Drug Administration (FDA).
Eligibility
- * Non-penetrating traumatic brain injury
- * Glasgow Coma Scale (GCS) 3-8 measured off paralytics
- * Glasgow Coma Scale motor score \< 6 if endotracheally intubated
- * Evidence of intracranial trauma on CT scan
Show more
Inclusion Criteria:
- * Non-penetrating traumatic brain injury
- * Glasgow Coma Scale (GCS) 3-8 measured off paralytics
- * Glasgow Coma Scale motor score \< 6 if endotracheally intubated
- * Evidence of intracranial trauma on CT scan
- * Able to place intracranial probes and randomize within 6 hours of arrival at enrolling hospital
- * Able to place intracranial probes and randomize within 12 hours from injury
- * Age greater than or equal to 14 years
Exclusion Criteria:
- * Non-survivable injury
- * Bilaterally absent pupillary response in the absence of paralytic medication
- * Contraindication to the placement of intracranial probes
- * Treatment of brain tissue oxygen values prior to randomization
- * Planned use of devices which may unblind treating physicians to brain tissue hypoxia
- * Systemic sepsis at screening
- * Refractory hypotension
- * Refractory systemic hypoxia
- * PaO2/FiO2 ratio \< 150
- * Known pre-existing neurologic disease with confounding residual neurological deficits
- * Known inability to perform activities of daily living (ADL) without assistance prior to injury
- * Known active drug or alcohol dependence that, in the opinion of site investigator, would interfere with physiological response to brain tissue oxygen treatments
- * Pregnancy
- * Prisoner
- * On EFIC Opt-Out list as indicated by a bracelet or medical alert
Show less
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase 3